Home

JDJ Bioservices is an Australian registered business headquartered in Melbourne which offers a broad range of drug discovery, development and consultancy services to assist the local and international biotechnology community. 

The company has laboratory operations in Australia and China, providing cost-effective chemistry and biology services, and can accommodate a broad range of projects from the smallest lead optimization program, screening for hit identification or validation, to a fully integrated hit discovery and lead optimization program. JDJ can also cost-effectively manufacture chemicals to the kilogram scale.

JDJ’s experienced scientific, business, non-clinical and clinical development consultants also offer a broad range consulting services, including independent internal and external project reviews and assessments, project due diligence and non-clinical and clinical development planning. Our experience in business development is also able to assist you with the in-licensing or out-licensing activities.

JDJ is an Approved Supplier under the Victorian Government's Small Technologies Industry Uptake Program (STIUP). The STIUP has been established to give Victorian Business the opportunity to increase their competitiveness by using small technologies to explore, adopt and integrate into improved products, processes and services. The Program provides support through a voucher system which can be exchanged for access to facilities, goods, services, advice or expertise. More information on the STIUP is available on www.stc-melbourne.com.

Scientific Services and Expertise
JDJ Bioservices offers state of the art, high quality, cost -effective value adding services and expertise in:

• Synthetic organic chemistry
• Medicinal chemistry
• Bio-assays, molecular biology and protein biochemistry

Non-Clinical and Clinical Development
JDJ Bioservices consults in drug development and through our alliances we can develop your non-clinical and clinical trial program and development strategy. Our team is experienced in multiple clinical areas including virology, CNS, pain, respiratory, oncology, inflammatory and infectious diseases and can provide:

• Development and management of non-clinical and clinical strategies in all therapeutic areas
• Establishment of advisory panels - SAB’s, DSMB and KOL panels
• Management of clinical projects in Australia, USA and Europe
• Development of regulatory strategies and submissions to regulatory authorities in Australia, USA and Europe

Business Development
JDJ Bioservices’ extensive industry experience can also assist with your business development needs, including:

• Technical and commercial evaluation of new biomedical technologies
• Due diligence preparation and evaluations
• Business case evaluation
• Business development - identification of potential licensing partners, assistance with in- and out-licensing discussions
• Market identification and product positioning
• Development pathway costing and capital raising requirement

Our business model
JDJ Bioservices has no proprietary discovery programmes and offers flexible service arrangements to meet the needs of its clients business, including:

• FTE (Full-time-equivalent) – a flat rate per scientist/consultant.
• FFS (Fee for service) – where the cost of a project is pre-agreed
• Risk-share – e.g. a milestone arrangement at a discount to the FTE or FFS charge but with an additional payment when the goal is achieved, or even for a share of future benefit